About us
Founded in 2012 and granted the qualification of biomedicine company by the Ministry of Economic Affairs in 2015, Energenesis Biomedical Co., Ltd. aspires to become a new star in biotech industry.
Information
- 2021-07 Energenesis Biomedical Announces Positive End-of-Phase 2 Meeting with FDA on ENERGI-F703 for the Treatment of Diabetic Foot Ulcers
- 2021-04 The Japan patent “Compound for Activating AMPK and Used Thereof” is granted.
- 2021-02 The Korean patent “Compound for Activating AMPK and Used Thereof” is granted.
- 2020-12 The Canada patent “Compound for Activating AMPK and Used Thereof” is granted.
- 2020-12 Energenesis Biomedical won the 17th National Innovation Award-Enterprise Innovation Award